Phage antirestriction induced system (PARIS) protects bacteria from viral infections by cleaving viral tRNAs and T5 phage escaping it by expression of a lysine transfer RNA variant that is not cleaved by PARIS
#armsRace #biology #bacteria #viruses
https://www.biorxiv.org/content/10.1101/2025.07.24.666596v1
https://www.nature.com/articles/s41586-024-07874-3
Bacterial Schlafens mediate anti-phage defense
Human Schlafen proteins restrict viral replication by cleaving tRNA, thereby suppressing protein synthesis. Although the ribonuclease domain of Schlafen proteins is conserved across all domains of life, its function in prokaryotes has remained unclear. Here, we show that prokaryotic Schlafen nucleases (pSlfns) are widespread antiviral effectors that protect bacteria from phages. These nucleases are fused to diverse protein domains that sense phage infection. We focus on a system where Schlafen nuclease is fused to a previously unknown immunoglobulin-like sensor domain and demonstrate that it recognizes T5-like phage tail assembly chaperones and cleaves both bacterial and viral tRNA, triggering abortive infection. Our findings redefine Schlafens as an ancient, mechanistically conserved family of immune effectors, revealing the deep evolutionary origin of tRNA-targeting antiviral immunity in humans. ### Competing Interest Statement A. Nemudryi and A. Nemudraia are inventors on patents and patent applications related to CRISPR-Cas and Schlafen immune systems and applications thereof. National Institutes of Health, R00AI171893







